Cargando…

Predicting Synergism of Cancer Drug Combinations Using NCI-ALMANAC Data

Drug combinations are of great interest for cancer treatment. Unfortunately, the discovery of synergistic combinations by purely experimental means is only feasible on small sets of drugs. In silico modeling methods can substantially widen this search by providing tools able to predict which of all...

Descripción completa

Detalles Bibliográficos
Autores principales: Sidorov, Pavel, Naulaerts, Stefan, Ariey-Bonnet, Jérémy, Pasquier, Eddy, Ballester, Pedro J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6646421/
https://www.ncbi.nlm.nih.gov/pubmed/31380352
http://dx.doi.org/10.3389/fchem.2019.00509
_version_ 1783437559042408448
author Sidorov, Pavel
Naulaerts, Stefan
Ariey-Bonnet, Jérémy
Pasquier, Eddy
Ballester, Pedro J.
author_facet Sidorov, Pavel
Naulaerts, Stefan
Ariey-Bonnet, Jérémy
Pasquier, Eddy
Ballester, Pedro J.
author_sort Sidorov, Pavel
collection PubMed
description Drug combinations are of great interest for cancer treatment. Unfortunately, the discovery of synergistic combinations by purely experimental means is only feasible on small sets of drugs. In silico modeling methods can substantially widen this search by providing tools able to predict which of all possible combinations in a large compound library are synergistic. Here we investigate to which extent drug combination synergy can be predicted by exploiting the largest available dataset to date (NCI-ALMANAC, with over 290,000 synergy determinations). Each cell line is modeled using primarily two machine learning techniques, Random Forest (RF) and Extreme Gradient Boosting (XGBoost), on the datasets provided by NCI-ALMANAC. This large-scale predictive modeling study comprises more than 5,000 pair-wise drug combinations, 60 cell lines, 4 types of models, and 5 types of chemical features. The application of a powerful, yet uncommonly used, RF-specific technique for reliability prediction is also investigated. The evaluation of these models shows that it is possible to predict the synergy of unseen drug combinations with high accuracy (Pearson correlations between 0.43 and 0.86 depending on the considered cell line, with XGBoost providing slightly better predictions than RF). We have also found that restricting to the most reliable synergy predictions results in at least 2-fold error decrease with respect to employing the best learning algorithm without any reliability estimation. Alkylating agents, tyrosine kinase inhibitors and topoisomerase inhibitors are the drugs whose synergy with other partner drugs are better predicted by the models. Despite its leading size, NCI-ALMANAC comprises an extremely small part of all conceivable combinations. Given their accuracy and reliability estimation, the developed models should drastically reduce the number of required in vitro tests by predicting in silico which of the considered combinations are likely to be synergistic.
format Online
Article
Text
id pubmed-6646421
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-66464212019-08-02 Predicting Synergism of Cancer Drug Combinations Using NCI-ALMANAC Data Sidorov, Pavel Naulaerts, Stefan Ariey-Bonnet, Jérémy Pasquier, Eddy Ballester, Pedro J. Front Chem Chemistry Drug combinations are of great interest for cancer treatment. Unfortunately, the discovery of synergistic combinations by purely experimental means is only feasible on small sets of drugs. In silico modeling methods can substantially widen this search by providing tools able to predict which of all possible combinations in a large compound library are synergistic. Here we investigate to which extent drug combination synergy can be predicted by exploiting the largest available dataset to date (NCI-ALMANAC, with over 290,000 synergy determinations). Each cell line is modeled using primarily two machine learning techniques, Random Forest (RF) and Extreme Gradient Boosting (XGBoost), on the datasets provided by NCI-ALMANAC. This large-scale predictive modeling study comprises more than 5,000 pair-wise drug combinations, 60 cell lines, 4 types of models, and 5 types of chemical features. The application of a powerful, yet uncommonly used, RF-specific technique for reliability prediction is also investigated. The evaluation of these models shows that it is possible to predict the synergy of unseen drug combinations with high accuracy (Pearson correlations between 0.43 and 0.86 depending on the considered cell line, with XGBoost providing slightly better predictions than RF). We have also found that restricting to the most reliable synergy predictions results in at least 2-fold error decrease with respect to employing the best learning algorithm without any reliability estimation. Alkylating agents, tyrosine kinase inhibitors and topoisomerase inhibitors are the drugs whose synergy with other partner drugs are better predicted by the models. Despite its leading size, NCI-ALMANAC comprises an extremely small part of all conceivable combinations. Given their accuracy and reliability estimation, the developed models should drastically reduce the number of required in vitro tests by predicting in silico which of the considered combinations are likely to be synergistic. Frontiers Media S.A. 2019-07-16 /pmc/articles/PMC6646421/ /pubmed/31380352 http://dx.doi.org/10.3389/fchem.2019.00509 Text en Copyright © 2019 Sidorov, Naulaerts, Ariey-Bonnet, Pasquier and Ballester. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Chemistry
Sidorov, Pavel
Naulaerts, Stefan
Ariey-Bonnet, Jérémy
Pasquier, Eddy
Ballester, Pedro J.
Predicting Synergism of Cancer Drug Combinations Using NCI-ALMANAC Data
title Predicting Synergism of Cancer Drug Combinations Using NCI-ALMANAC Data
title_full Predicting Synergism of Cancer Drug Combinations Using NCI-ALMANAC Data
title_fullStr Predicting Synergism of Cancer Drug Combinations Using NCI-ALMANAC Data
title_full_unstemmed Predicting Synergism of Cancer Drug Combinations Using NCI-ALMANAC Data
title_short Predicting Synergism of Cancer Drug Combinations Using NCI-ALMANAC Data
title_sort predicting synergism of cancer drug combinations using nci-almanac data
topic Chemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6646421/
https://www.ncbi.nlm.nih.gov/pubmed/31380352
http://dx.doi.org/10.3389/fchem.2019.00509
work_keys_str_mv AT sidorovpavel predictingsynergismofcancerdrugcombinationsusingncialmanacdata
AT naulaertsstefan predictingsynergismofcancerdrugcombinationsusingncialmanacdata
AT arieybonnetjeremy predictingsynergismofcancerdrugcombinationsusingncialmanacdata
AT pasquiereddy predictingsynergismofcancerdrugcombinationsusingncialmanacdata
AT ballesterpedroj predictingsynergismofcancerdrugcombinationsusingncialmanacdata